SEC Form 4 research
| Issuer | Quoin Pharmaceuticals, Ltd. |
|---|---|
| Tickers | QNRX |
| Reporting owners | 10 |
| Officers and directors | 4 |
| Last public filing | 2026-09-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-01 | 2026-08-31 | Carter Denise P. | P | 20,490 | $4.88 | Not reported |
| 2026-09-01 | 2026-08-31 | Carter Denise P. | P | 10,245 | Not reported | Not reported |
| 2026-09-01 | 2026-08-31 | Myers Michael | P | 20,490 | $4.88 | Not reported |
| 2026-09-01 | 2026-08-31 | Myers Michael | P | 10,245 | Not reported | Not reported |
| 2026-09-01 | 2026-08-31 | Lawlor Sally Bridget | P | 10,244 | $4.88 | Not reported |
| 2026-09-01 | 2026-08-31 | Lawlor Sally Bridget | P | 5,122 | Not reported | Not reported |
| 2026-09-01 | 2026-08-31 | Culverwell Anthony James | P | 6,146 | $4.88 | Not reported |
| 2026-09-01 | 2026-08-31 | Culverwell Anthony James | P | 3,073 | Not reported | Not reported |
| 2026-08-28 | 2026-08-27 | LANGER DENNIS | A | 34,534 | $5.15 | Not reported |
| 2026-08-28 | 2026-08-27 | Culverwell Anthony James | A | 31,352 | $5.15 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.